A new research paper was published by Aging (Aging-US) on January 8, 2025, in Volume 17, Issue 1, titled "Senolytic agent ABT-263 mitigates low- and high-LET radiation-induced gastrointestinal cancer ...
“Our results offer ‘proof of concept’ for the future use of a pharmaceutical senolytic strategy to reduce the risk of IR-induced GI cancer.” “Our results offer ‘proof of concept’ for the future use of ...
Conducted under a research agreement with Gustave Roussy and its technology transfer affiliate, Gustave Roussy Transfert, this collaboration will combine StarkAge’s expertise in senescence biology ...
LONDON, Nov. 27, 2023 (GLOBE NEWSWIRE) -- Myricx Bio (‘Myricx’), a UK biotech company focused on the discovery and development of a completely novel class of antibody-drug conjugate (ADC) payloads ...
Research conducted by Gustave Roussy will help StarkAge move STX-01, an antibody-drug conjugate targeting senescent cells, toward clinical trials.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results